Learn More
Medchemexpress LLC MSX-122 | 897657-95-3 | MFCD18803971 | 98.2% | 292.34 g/mol | C16H16N6 | 5 MG

Supplier: Medchemexpress LLC HY136965MG
MSX-122 is an orally active small-molecule partial antagonist of the chemokine receptor CXCR4. It inhibits CXCR4/CXCL12 signaling with an IC50 of ≈10 nM and has reported anti-inflammatory and anti-metastatic activity. Supplied as a light yellow solid powder for laboratory research, the compound is used in preclinical studies of inflammation, metastasis, and CXCR4-mediated signaling.
- Partial antagonist of CXCR4 (IC50 ≈ 10 nM).
- Orally bioavailable small-molecule for in vivo and in vitro studies.
- Molecular formula C16H16N6; molecular weight 292.34 g/mol.
- Reported purity ≈98.2%.
- Soluble in DMSO (~4 mg/mL); multiple in vivo formulation options reported.
- Light yellow powder; recommended storage -20°C for powder, -80°C for solutions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.